CADCA Publisher June 14, 2016
BLOG POST

Milwaukee Community Leaders Unite to Address Local Opioid Epidemic

Summit is cornerstone of DEA’s 360 Strategy

WHAT:           More than 200 community advocates will gather at the Key Influencers Summit: Addressing Milwaukee’s Opioid Epidemic. The event, hosted by the Drug Enforcement Administration (DEA) and CADCA (Community Anti-Drug Coalitions of America) is an integral component of the DEA’s 360 Strategy, which launched in Milwaukee earlier this year. The summit will unite community leaders to focus on key sectors, which are critical in influencing behavior change: faith, families, education, law enforcement, and the healthcare continuum. Attendees will gain in-depth insights on the national and local opioid landscape and develop tangible strategies targeted at the issue that they can implement within their sphere of influence.

WHEN:           June 15, 2016 from 9:30 a.m.- 4:00 p.m.

WHERE:         Italian Community Center
                      Grand Ballroom

                      631 E. Chicago St.

                      Milwaukee, WI 53202 

EXPERTS AVAILABLE FOR INTERVIEWS:

  • Dennis Wichern, Special Agent in Charge, DEA, Chicago Field Division
  • Neil Doherty, Associate Deputy Assistant Administrator, DEA
  • Sean Fearns, Chief, Community Outreach, DEA
  • Robert Bell, Assistant Special Agent in Charge, DEA, Milwaukee District Office
  • Carlton Hall, Deputy Director, Training and Technical Assistance, CADCA
  • Katie Sanders, Executive Director, Safe & Sound
  • Kari Lerch, Deputy Director, Community Advocates Public Policy Institute
  • Local substance abuse prevention and treatment experts

About DEA 360 Strategy
The DEA 360 Strategy takes an innovative three-pronged approach to combating prescription opioid and heroin abuse through: (1) coordinated law enforcement actions against drug cartels and heroin traffickers in specific communities; (2) Diversion Control enforcement actions against DEA registrants operating outside the law and long-term engagement with pharmaceutical drug manufacturers, wholesalers, pharmacies, and practitioners; and (3) community outreach through local partnerships that empower communities to take back affected neighborhoods after enforcement actions and prevent the same problems from cropping up again.

Browse Our Blog